Severity of disease – Communicable Diseases Research

Changes of Routine Hematological Parameters in COVID-19 Patients: Correlation with Imaging Findings, RT-PCR and Outcome

Original Article

Published on 2022-12-152022-10-29
Journal: Iranian Journal of Pathology [Category] COVID-19,

[키워드] Admission age analyses Biochemical parameters Blood change Chest chest imaging Chest tomography Concentration Coronavirus disease 2019 correlated correlation correlations COVID-19 COVID-19 case COVID-19 patient Critical CRP CT-scan demonstrated diagnosed Diagnosis during admission enrolled evaluated expired group hematologic hematology hemoglobin Hospitalized imaging investigated Laboratory LDH less leukocyte lung lung involvement Lymphocytes neutrophil no increase outcome parameter parameters participant Patient patients Platelet platelets count Prognostic value raise researcher respiratory viral routine RT-PCR severity Severity of disease the disease tomography Tomography scanners upper respiratory Viral load WBC were measured White blood cells
[DOI] 10.30699/IJP.2021.533645.2675 PMC 바로가기 [Article Type] Original Article

Clinical utility of circulating calprotectin to assist prediction and monitoring of COVID-19 severity: An Italian study

Article

Published on 2022-12-012022-11-15
Journal: Journal of medical virology [Category] 바이오마커,

Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death

Article

Published on 2022-11-052022-11-15
Journal: Scientific Reports [Category] SARS, 바이오마커, 진단,

Evaluation of Procalcitonin’s Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients

Article

Published on 2022-11-012022-11-15
Journal: Journal of Intensive Care Medicine [Category] 바이오마커,

[키워드] Antibiotic therapy AUC Bacteremia Bacterial Bacterial infection bacterial pneumonia baseline characteristics Concomitant conducted COVID-19 creatinine Critical Critical illness Critically ill patient Culture defined determine diagnosing diagnostic ENhance evaluate group hospitalized patients ICU ICU patient identify Ill in-hospital mortality intensive care intensive care unit Mortality multivariable multivariable model no difference no significant difference offer outcome Patient PCT Pneumonia positive predict Predictive procalcitonin receiver operating characteristics Regression model retrospective cohort study ROC SARS-CoV-2 secondary bacterial pneumonia serum creatinine Severe COVID-19 pneumonia Severity of disease specificity threshold utility variable vital signs was used while with COVID-19
[DOI] 10.1177/08850666221108636 PMC 바로가기

Evaluation of qualitative and semi-quantitative cut offs for rapid diagnostic lateral flow test in relation to serology for the detection of SARS-CoV-2 antibodies: findings of a prospective study

Article

Published on 2022-10-312022-11-15
Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 진단, 치료기술,

[키워드] 95% CI Accuracy acute respiratory syndrome Analysis antibodies antibody Antibody detection assessments Blood capillary blood chemiluminescent immunoassay CLIA coronavirus coronavirus disease COVID-19 COVID-19 disease cut off cut-off Diagnosis diagnosis of COVID-19 diagnostic Efficacy ELISA evaluate facilitate gold standard identify IgM and IgG immunochromatographic assay information intensity Italy Laboratory Lateral lateral flow lateral flow immunoassay Lateral flow test measure NAAT Non-invasive nucleic acid amplification Patient patients performed POC positive Prospective Study provided Quantitative Rapid Rapid diagnostic test RDT SARS-CoV-2 SARS-CoV-2 antibody semi-quantitative sensitivity serological test serology Severity of disease specificity symptom onset Test the timing venous whole sample
[DOI] 10.1186/s12879-022-07786-5 PMC 바로가기

Metagenomic analysis reveals differences in the co-occurrence and abundance of viral species in SARS-CoV-2 patients with different severity of disease

Article

Published on 2022-10-192022-11-15
Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 치료기술, 치료제,

Association of human myxovirus resistance protein A with severity of COVID-19

Article

Published on 2022-09-282022-11-15
Journal: BMC Infectious Diseases [Category] 바이오마커,

Severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid Antigen in Urine of Hospitalized Patients With Coronavirus Disease 2019

Article

Published on 2022-09-132022-11-15
Journal: The Journal of Infectious Diseases [Category] SARS, 진단, 치료기술,

Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China

Article

Published on 2022-09-012022-11-16
Journal: JAMA Network Open [Category] SARS, 변종,

[키워드] 95% CI acute illness Admission age Analysis Anxiety change Chest China chronic obstructive cohort study conducted COVID-19 decrease defined discharge Dyspnea Factor fatigue Follow-up follow-up study follow-up visits Health higher risk hospital hospital discharge Hospitalization hospitalized COVID-19 identify incidence increased risk Infection intensive care IQR longitudinal cohort study male median MOST myalgia Odds ratio omicron outcome Patient patients who survived patients with COVID-19 persistence pulmonary disease questionnaire required resolved severe disease Severity of disease survivor Survivors Symptom symptom burden Symptoms total score variant virus World Health Organization worsening Wuhan, China
[DOI] 10.1001/jamanetworkopen.2022.31790 PMC 바로가기

Obesity, Hypovitaminosis D, and COVID-19: the Bermuda Triangle in Public Health

비만, 비타민 D 부족 및 COVID-19: 공중 보건의 버뮤다 삼각지대

Review

Published on 2022-09-012022-09-11
Journal: Current obesity reports [Category] COVID19(2023년), SARS, 유전자 메커니즘,

[키워드] acute respiratory distress acute respiratory distress syndrome association body mass body mass index convergence COVID-19 COVID-19 pandemic COVID-19 susceptibility death Evidence explain Genetic genetic data genetic evidence Genome-wide association studies Genome-wide association study higher risk highlighting Hospitalization hypovitaminosis Hypovitaminosis D independent risk factor Infectious complications measure morbidity and mortality obesity outcomes pandemic Pandemics potential mechanism potential mechanisms Prevalence prevalent Public public health recent required respiratory distress risk risk factor robust SARS-CoV-2 SARS-COV-2 infection severe disease severity Severity of disease shown subject suggested syndrome therapeutic Treatment treatment of COVID-19 Triangle Vitamin D vitamin D level vitamin D levels Vitamin D supplementation
[DOI] 10.1007/s13679-022-00471-3 PMC 바로가기 [Article Type] Review